We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXE:NASDAQExpand Energy Corporation Analysis

Data as of 2026-05-22 - not real-time

$97.59

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Expand Energy (EXE) is trading at roughly $97.6, far below its DCF‑derived fair value of about $240, indicating a substantial discount. Revenue surged 41% YoY to $12.96 B and margins remain robust, with a gross margin near 48% and operating margin above 34%. The company generated $1.70 B of free cash flow in Q1 2026, cut net debt by $1.3 B and returned $290 M to shareholders, supporting a 3.23% dividend yield with a modest 24% payout ratio. Analyst consensus is bullish, with a “buy” recommendation and a mean target price of $130.9, implying upside of over 30%.
Technical signals are mixed: the price sits below the 20‑, 50‑ and 200‑day SMAs, the trend is classified as bearish, and volume is decreasing, yet the MACD histogram is positive and the RSI sits near the neutral zone, suggesting limited short‑term downside. Low beta (≈0.08) and a 30‑day volatility of ~24% point to modest market‑wide risk, while sector‑specific commodity and regulatory exposures remain medium. Overall, the stock appears undervalued with strong cash generation and dividend sustainability, but investors should monitor energy‑price dynamics and regulatory developments.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Q1 earnings beat and strong free cash flow
  • Attractive dividend yield with low payout ratio
  • Positive MACD histogram despite bearish price trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of >30% and low price multiples versus industry
  • Sustained revenue growth of 41% YoY
  • Solid balance sheet with declining net debt

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to commodity price and regulatory cycles
  • Consistent dividend income and cash generation
  • Potential capital allocation toward low‑carbon initiatives

Key Metrics & Analysis

Financial Health

Revenue Growth41.00%
Profit Margin24.91%
P/E Ratio7.4
ROE17.57%
ROA9.67%
Debt/Equity25.88
P/B Ratio1.2
Op. Cash Flow$5.9B
Free Cash Flow$1.7B
Industry P/E21.5

Technical Analysis

TrendBearish
RSI46.8
Support$94.47
Resistance$102.96
MA 20$98.09
MA 50$101.35
MA 200$104.82
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5

Valuation

Fair Value$240.24
Target Price$130.92
Upside/Downside34.15%
GradeUndervalued
TypeBlend
Dividend Yield3.23%

Risk Assessment

Beta0.08
Volatility24.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.